Biomea Fusion (BMEA) Stock Forecast, Price Target & Predictions
BMEA Stock Forecast
Biomea Fusion (BMEA) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $23.33, with a high of $40.00 and a low of $11.00. This represents a 553.50% increase from the last price of $3.57.
BMEA Stock Rating
Biomea Fusion stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
BMEA Price Target Upside V Benchmarks
Type | Name | Upside |
---|---|---|
Stock | Biomea Fusion | 553.50% |
Sector | Healthcare Stocks | 25.10% |
Industry | Biotech Stocks | 61.24% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 7 |
Avg Price Target | - | - | $17.29 |
Last Closing Price | $3.57 | $3.57 | $3.57 |
Upside/Downside | - | - | 384.31% |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Feb, 25 | 3 | 4 | 2 | - | - | 9 |
Jan, 25 | 3 | 4 | 2 | - | - | 9 |
Dec, 24 | 3 | 4 | 2 | - | - | 9 |
Nov, 24 | 3 | 5 | 3 | - | - | 11 |
Oct, 24 | 3 | 5 | 3 | - | - | 11 |
Analyst Price Target Forecasts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 31, 2024 | Joseph Catanzaro | Piper Sandler | $19.00 | $10.34 | 83.75% | 432.21% |
Oct 30, 2024 | Peter Lawson | Barclays | $11.00 | $12.06 | -8.79% | 208.12% |
Oct 22, 2024 | Joseph Pantginis | H.C. Wainwright | $40.00 | $11.24 | 255.87% | 1020.45% |
Sep 27, 2024 | Joseph Catanzaro | Piper Sandler | $10.00 | $9.90 | 1.01% | 180.11% |
Jun 07, 2024 | Joseph Pantginis | H.C. Wainwright | $15.00 | $4.24 | 253.77% | 320.17% |
Jun 07, 2024 | George Farmer | Scotiabank | $21.00 | $11.27 | 86.34% | 488.24% |
Jun 07, 2024 | Peter Lawson | Barclays | $5.00 | $11.27 | -55.63% | 40.06% |
Jun 14, 2022 | Joseph Pantginis | H.C. Wainwright | $16.00 | $8.50 | 88.24% | 348.18% |
Analyst Rating Forecasts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | Piper Sandler | Overweight | Overweight | hold |
Oct 30, 2024 | Barclays | Equal-Weight | Equal-Weight | hold |
Oct 22, 2024 | H.C. Wainwright | Buy | Buy | hold |
Oct 09, 2024 | EF Hutton | Buy | initialise | |
Sep 27, 2024 | Scotiabank | Outperform | Outperform | hold |
Sep 27, 2024 | Piper Sandler | Overweight | Overweight | hold |
Sep 27, 2024 | Scotiabank | Sector Outperform | Sector Outperform | hold |
Sep 27, 2024 | H.C. Wainwright | Buy | Buy | hold |
Sep 27, 2024 | Barclays | Equal-Weight | Equal-Weight | hold |
Sep 26, 2024 | Rodman & Renshaw | Neutral | Buy | upgrade |
Financial Forecast
EPS Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-3.44 | - | - | - | - | - |
Avg Forecast | $-3.32 | $-3.89 | $-3.55 | $-3.30 | $-3.38 | $-2.13 |
High Forecast | $-3.14 | $-3.44 | $-2.82 | $-0.84 | $-0.88 | $-2.13 |
Low Forecast | $-3.50 | $-4.18 | $-4.30 | $-5.24 | $-4.97 | $-2.13 |
Surprise % | 3.61% | - | - | - | - | - |
Revenue Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | - | - | - | - | - | - |
Avg Forecast | - | $10.00M | $1.88M | $4.33M | $29.19M | $198.99M |
High Forecast | - | $10.00M | $1.88M | $4.33M | $29.19M | $198.99M |
Low Forecast | - | $10.00M | $1.88M | $4.33M | $29.19M | $198.99M |
Surprise % | - | - | - | - | - | - |
Net Income Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-117.25M | - | - | - | - | - |
Avg Forecast | $-107.69M | $-130.06M | $-121.44M | $-161.05M | $-163.59M | $-72.79M |
High Forecast | $-107.02M | $-117.41M | $-96.21M | $-28.75M | $-30.15M | $-72.79M |
Low Forecast | $-119.37M | $-142.71M | $-146.68M | $-178.61M | $-169.36M | $-72.79M |
Surprise % | 8.89% | - | - | - | - | - |